The latest update is out from Arvinas Holding Company (ARVN).
Arvinas, Inc. has appointed Andrew Saik as its new CFO, treasurer, and principal financial officer. Saik, with over two decades of biopharmaceutical finance experience, previously held CFO roles at Intercept Pharmaceuticals and other firms, showcasing a track record of financial leadership and capital raising. His compensation includes a $525,000 base salary, up to 45% performance-based bonus, and equity incentives, with specific vesting conditions and termination clauses providing security and incentives aligned with the company’s success.
Find detailed analytics on ARVN stock on TipRanks’ Stock Analysis page.
